Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 94 (RPL21P94)

Target
RPL21P94
Molecular classification
Other (Pseudogene)
01

Overview

RPL21P94 (ribosomal protein L21 pseudogene 94) is a pseudogene, meaning it is a non-functional genomic sequence derived from the ribosomal protein L21 gene (RPL21)[2][5]. While the functional RPL21 encodes a structural protein component of the 60S ribosomal subunit involved in protein synthesis[1][4][7], RPL21P94 represents one of many processed pseudogenes generated by retrotransposition events in the genome[2][3]. Pseudogenes such as RPL21P94 typically do not encode functional proteins and are not considered drug targets or biologically active molecules. This designation as a pseudogene is supported by systematized pseudogene annotations found in the GENCODE project and large-scale pseudogene inventories[2][3]. There is no evidence RPL21P94 is involved in disease or interacts with any drugs. Its most accurate classification is "Other (Pseudogene)" in molecular terms. Additional context: The parent gene, RPL21, is associated with ribosome assembly and, in its functional form, with cellular protein synthesis and hereditary disease (Hypotrichosis simplex)[1][4][7]. However, these properties do not apply to the pseudogene RPL21P94. Summary: RPL21P94 is a non-functional pseudogene, not a therapeutic target or biologically relevant molecule for clinical or pharmacological consideration[2][3][5].

Other names
RPL21_39_1117RPL21P94

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 94 (RPL21P94).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 94 (RPL21P94).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call